Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies
Open Access
- 19 January 2022
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 60 (1) , e0159721
Abstract
Rubella and congenital rubella syndrome are caused by the rubella virus and are preventable through vaccination, making disease eradication possible. Monitoring of progress toward global eradication and local elimination requires high-quality, sensitive disease surveillance that includes laboratory confirmation of cases.Keywords
Funding Information
- Public Health Agency of Canada (N/A)
This publication has 19 references indexed in Scilit:
- Challenges of measles and rubella laboratory diagnostic in the era of eliminationClinical Microbiology and Infection, 2017
- Dilemmas and Pitfalls in Rubella Laboratory Diagnostics in Low Prevalence or Elimination SettingsCurrent Treatment Options in Infectious Diseases, 2016
- Laboratory confirmation of rubella infection in suspected measles casesJournal of Medical Virology, 2016
- Framework for verifying elimination of measles and rubella.2013
- False-Positive Results for Immunoglobulin M Serologic Results: Explanations and ExamplesJournal of the Pediatric Infectious Diseases Society, 2013
- Guidelines for the Documentation and Verification of Measles, Rubella, and Congenital Rubella Syndrome Elimination in the Region of the AmericasThe Journal of Infectious Diseases, 2011
- Comparison of three enzyme immunoassays used to detect human parvovirus B19-specific IgM antibodies in sera of people suspected of measles.2010
- Evaluation of rubella IgM enzyme immunoassaysJournal of Clinical Virology, 2004
- Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infectionJournal of Clinical Virology, 1999
- Two-sided confidence intervals for the single proportion: comparison of seven methodsStatistics in Medicine, 1998